Approval · Notice of Compliance 2613 · 2001
ISOPTIN: Notice of Compliance 2613
Issued April 17, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2613
- Date
- April 17, 2001
- Company
- Knoll Pharma Inc.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised formulation
- Therapeutic class
- Antianginal/antihypertensive/antiarrhythmic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ISOPTIN | Not yet assigned | — |
Medicinal ingredients
- VERAPAMIL HCL 80 MG per TAB
- VERAPAMIL HCL 120 MG per TAB